Skip to content

ResMed RMD Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
26.3×-20.7×
Insmed logo
InsmedINSM
50×-89.2×
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
-1.0×
Boston Scientific logo
Boston ScientificBSX
3.6×-3.1×
Intuitive Surgical logo
Intuitive SurgicalISRG
9.4×-1.0×
Abbott logo
AbbottABT
3.4×-1.3×

Other financials

Income statement

See full
Revenue$1.4B+10.8%
Gross profit$891.0M+16.3%
Operating income$499.8M+17.3%
Net income$398.7M+9.2%
EPS (diluted)$2.74+10.5%

Balance sheet

See full
Cash & equivalents$1.7B+78.0%
Total debt$1.1B+29.8%
Total equity$6.5B+17.1%
Total assets$8.8B+16.1%

Cash flow

See full
Operating cash flow$554.1M-4.2%
CapEx$33.7M+61.8%
Free cash flow$520.5M-6.7%

Valuation

See full
Market cap$27.36B-0.5%
Enterprise value$26.8B-2.0%
P/E18×-2.9×
P/S4.9×-0.5×

Profitability

See full
Gross margin61.6%+2.8pp
Operating margin34.2%+2.1pp
Net margin27.4%+1.3pp

Returns & leverage

See full
Return on equity25.2%-0.6pp
Debt / equity0.2×0.0×
Current ratio-0.4×

Where this comes from

Calculated from ResMed’s reported figures.

Based on the most recent quarter.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ResMed's price / book?
ResMed (RMD) reported price / book of 5× in Q1 2026.
How has ResMed's price / book changed year-over-year?
ResMed's price / book decreased by 15.0% year-over-year, from 5.9× to 5×.
What is the long-term trend for ResMed's price / book?
Over 4 years (2021 to 2025), ResMed's price / book has grown at a -12.2% compound annual growth rate (CAGR), from 43× to 25.5×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.